Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Synalar 25 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Synalar 25

Approved

STANDARD

Synalar 25

Interphil Laboratories, Inc.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 71eaab821d17c156
Company: Interphil Laboratories, Inc.
Type: Standard

Approval Details

Approval Id: 71eaab821d17c156
Drug Approval Philippines Name: Synalar 25
Product Name: Synalar 25
Registration Number: DR-8396
Brand Name: Synalar 25
Generic Name: Fluocinolone Acetonide
Dosage Form: Ointment
Dosage Strength: 250mcg per gram (0.025% w/v)
Manufacturer: Interphil Laboratories, Inc.
Trader: EURO-MED LABORATORIES PHIL., INC.
Issuance Date: 26 November 2021
Expiry Date: 30 January 2027
Pharmacologic Category: Corticosteroid
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

71eaab821d17c156

Type

Standard

Back to Philippines FDA Approvals